State Stem Cell Agency ICOC Agenda 5/12/09

May 12, 2009
Main Location: 

CIRM
210 King Street
San Francisco, CA 94107

Additional Locations: 
Sherry Lansing Foundation 2121 Avenue of the Stars Los Angeles, CA 90067
UC Davis School of Medicine 4610 X Street, Suite 3103 Sacramento, CA 95817
Salk Institute 10010 North Torrey Pines Road La Jolla, CA 92037
CONNECT 8950 Villa La Jolla Drive Suite A124 La Jolla, CA 92037
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
University of California, Berkeley 200 California Hall Berkeley, CA 94720
8170 Laguna Blvd., #101 Elk Grove, CA 95758
330 Plaza Street Healdsburg, CA 95448
University of California, Irvine 160 Aldrich Hall Irvine, CA 92697-3175
2476 Lancelot Lane Los Angeles, CA 90077
5 Via Delizia Hillsborough, CA 94010
2815 Sugarman La Jolla, CA 92037
855 Katella St. Laguna Beach, CA 92651
136 Roanoke Street San Francisco, CA 94131
Stanford University Clark Center, S363 318 Campus Drive Stanford, CA 94305
226 S. Stanley Dr. Beverly Hills, CA 90211
UCSF Laurel Heights 3333 California Street Room LH 150 San Francisco, CA 94118
San Francisco City Attorney's Office San Francisco International Airport International Terminal, 5th Floor San Francisco, CA 94128
11480 North Torrey Pines La Jolla, CA 92037
UCLA School of Medicine Office of the Dean 10833 Le Conte Avenue Los Angeles, CA 90095
Call-in Information: 
URL: http://65.197.1.15/att/confcast Enter Conference ID#: 100945, then click "Go".

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

MEETING NOTICE AND AGENDA
SPECIAL MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

  1. Call to Order 
  2. Roll Call

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

  3. Consideration of CIRM’s response to NIH draft guidelines during 30-day public comment period.

    • CIRM Draft Response to NIH Draft Guidelines — UPDATED FOLLOWING 5/12/09 ICOC TELECONFERENCE

  4. Consideration of CIRM’s statement of principles relating to federal biosimilar legislation (HR 1427 and 1548).
  5. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.


**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

Transcripts: 

© 2013 California Institute for Regenerative Medicine